SOPHiA GENETICS SA
Health technology company
SOPH Nasdaq
ISIN CH1125843347 SEC CIK 1840706
Follow SOPHiA GENETICS
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $77.3M | −$79M |
| FY24 | $65.2M | −$62.5M |
| FY23 | $62.4M | −$79M |
| FY22 | $47.6M | −$87.4M |
| FY21 | $40.5M | −$73.7M |
| FY20 | $28.4M | −$39.3M |
| FY19 | $25.4M | −$33.8M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 67.4% | −91.8% | −102.2% |
| FY24 | 67.4% | −102.1% | −95.9% |
| FY23 | 68.8% | −120% | −126.6% |
| FY22 | 65.7% | −184.7% | −183.9% |
| FY21 | 62.4% | −176.7% | −182.1% |
| FY20 | 62.3% | −131.6% | −138.5% |
| FY19 | 70.3% | - | −133.2% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$36.5M |
| FY24 | −$44.8M |
| FY23 | −$54.7M |
| FY22 | −$74.2M |
| FY21 | −$60.6M |
| FY20 | −$32.2M |
| FY19 | −$33M |
| FY18 | - |
- SOPHiA GENETICS
- Technology median
Show the numbers
| Year | SOPHiA GENETICS | Technology median |
|---|---|---|
| FY25 | −102.2% | −2.3% |
| FY24 | −95.9% | −5% |
| FY23 | −126.6% | −6.7% |
| FY22 | −183.9% | −4.4% |
| FY21 | −182.1% | −1.7% |
| FY20 | −138.5% | −3% |
| FY19 | −133.2% | 0% |
| FY18 | - | 0.8% |